We found that knockdown of HSF1 sensitizes cancer cells to HSP90 inhibitors in many different cancer lineages, including melanoma (A375, A2058), hepatocellular carcinoma (Hep3B, Huh7) and colon cancer (HCT116). This evidence concerns the gene HSF1 and colonic neoplasm.